Get started
Author

Davood Gheidari

Observed names: Davood Ghaidari, Gheidari, Davood
ORCID: 0000-0003-2106-1753
Observed ORCID: 0000-0003-2106-1753
OpenAlex ID: A5001650685
Synthesis and potent antimicrobial activity of CoFe2O4 nanoparticles under visible light
2020 · Davood Gheidari, Morteza Mehrdad, et al. · Heliyon · 90
Synthesis, docking, MD simulation, ADMET, drug likeness, and DFT studies of novel furo[2,3-b]indol-3a-ol as promising Cyclin-dependent kinase 2 inhibitors
2024 · Davood Gheidari, Morteza Mehrdad, et al. · Scientific Reports · 55
PDF
Virtual screening, ADMET prediction, molecular docking, and dynamic simulation studies of natural products as BACE1 inhibitors for the management of Alzheimer’s disease
2024 · Davood Gheidari, Morteza Mehrdad, et al. · Scientific Reports · 52
PDF
Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPKERK inhibitors
2024 · Davood Gheidari, Morteza Mehrdad, et al. · Frontiers in Pharmacology · 48
In silico evaluation of cis-dihydroxy-indeno[1,2-d]imidazolones as inhibitors of glycogen synthase kinase-3: synthesis, molecular docking, physicochemical data, ADMET,MD simulation, and DFT calculations
2024 · Nahid Mahmoodi, Mohammad Bayat, et al. · Journal of Saudi Chemical Society · 33
Synthesis, molecular docking, pharmacological evaluation, MD simulation, and DFT calculations of quinazolin-12-one derivatives as PDK1 inhibitors
2025 · Zahra Sadeghian, Mohammad Bayat, et al. · Nanoscale Advances · 29
PDF
Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitors
2025 · Zeinab Amiri, Mohammad Bayat, et al. · BMC Chemistry · 28
PDF
Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents
2024 · Fatemeh Aghahosseini, Mohammad Bayat, et al. · PLoS ONE · 25
PDF
Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors
2024 · Davood Gheidari, Morteza Mehrdad, et al. · PLoS ONE · 24
PDF
The quinazoline-2,4(1H,3H)-diones skeleton: A key intermediate in drug synthesis
2022 · Davood Gheidari, Morteza Mehrdad, et al. · Sustainable Chemistry and Pharmacy · 23
Recent advances in synthesis of quinazoline‐2,4( 1H,3H )‐diones: Versatile building blocks in N ‐heterocyclic compounds
2022 · Davood Gheidari, Morteza Mehrdad, et al. · Applied Organometallic Chemistry · 23
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
2025 · Davood Gheidari, Morteza Mehrdad, et al. · Frontiers in Drug Discovery · 19
PDF
Novel indenopyrrol-4-one derivatives as potent BRDT inhibitors: synthesis, molecular docking, drug-likeness, ADMET, and DFT studies
2023 · Davood Gheidari, Morteza Mehrdad, et al. · Journal of Biomolecular Structure and Dynamics · 17
Green Lewis Acid Catalysis in Organic Reactions
2022 · Mohammad Bayat, Davood Gheidari · ChemistrySelect · 16
In Silico Study of Bis(6‐Amino‐1,3‐Dimethylpyrimidine‐2,4(1H,3H)‐Diones) as EGFR Inhibitors: Synthesis, DFT, Molecular Docking, and MD Simulation Studies
2025 · Zeynab masoumi, Mohammad Bayat, et al. · Cellular Microbiology · 14
PDF
Recent advances in synthesis of ketenimines
2022 · Mohammad Bayat, Davood Gheidari, et al. · Arabian Journal of Chemistry · 12
Computational studies on structural aspects of pyrazolo[3,4-b]pyridine derivatives as TRKA inhibitors in cancer therapy
2025 · Davood Gheidari, Morteza Mehrdad, et al. · Scientific Reports · 11
PDF
Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors
2025 · Moeid Goudarzi Karim, Morteza Mehrdad, et al. · PLoS ONE · 8
PDF
Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
2021 · Davood Gheidari, Morteza Mehrdad, et al. · Frontiers in Chemistry · 6
PDF
Synthesis of CoFe2O4/BiOI nanocomposite; Its application as an antibacterial agent
2022 · Davood Gheidari, Morteza Mehrdad, et al. · Applied Organometallic Chemistry · 3
PDF
Current treads of targeted nanoparticulate carriers for the treatment of Alzheimer’s disease
2022 · Davood Gheidari, Mohammad Bayat · Elsevier eBooks · 3
Nanoparticles and liver cancer
2020 · Mohammad Bayat, Davood Ghaidari · Elsevier eBooks · 3
Targeting CDK8 in Cancer therapy: computational discovery of a novel inhibitor via docking, MM-GBSA, molecular dynamics simulations, and pharmacokinetic profiling
2026 · Davood Gheidari, Morteza Mehrdad · Results in Chemistry · 1
Integrated experimental and computational study of a novel indenonaphthodiazepine[5.3.3]propellane as a potential inhibitor of Mcl-1
2026 · Sahar Bagheri Bijarbone, Mohammad Bayat, et al. · Nanoscale Advances
PDF
Works count: 26
Citation count: 543
H-index: 14
I10-index: 17
Year
Topic
Type